Company research / CGON
CG Oncology, Inc. (CGON)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, CG Oncology, Inc. reported revenue of $4.04M. Revenue grew 254.7% from the prior annual period.
Key ratios (year ended 2025-12-31)
-4722.1%
Operating margin
-3985.0%
Net margin
-21.4%
Return on year-end equity
254.7%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.